Informatics

The goal of health informatics systems is to enable smooth transfer of data and cybersecurity across the healthcare enterprise. This includes patient information, images, subspecialty reporting systems, lab results, scheduling, revenue management, hospital inventory, and many other health IT systems. These systems include the electronic medical record (EMR) admission discharge and transfer (ADT) system, hospital information system (HIS), radiology picture archiving and communication systems (PACS), cardiovascular information systems (CVIS), archive solutions including cloud storage and vendor neutral archives (VNA), and other medical informatics systems.

RSS icon
Thumbnail

HIMSS18: 5 questions with CHIME-HIMSS CIO of the Year Randy McCleese

Randy McCleese, MSIS, MBA, the chief information officer at Methodist Hospital in Henderson, Kentucky, was selected as the 2017 CIO of the Year by College of Healthcare Information Management Executives (CHIME) and the Healthcare Information and Management Systems Society (HIMSS), with the groups specifically citing his IT advocacy on behalf of smaller, rural providers.

Thumbnail

Blockchain named most overhyped IT trend by CIOs

While applications of blockchain technology for healthcare have become a hot topic among health IT professionals, especially at conferences, a survey of chief information officers (CIOs) said they believe it’s the most overhyped trend in the field in terms of making an impact within the next two years.

Thumbnail

Randy McCleese named CHIME-HIMSS CIO of the Year

The College of Healthcare Information Management Executives (CHIME) and the Healthcare Information and Management Systems Society (HIMSS) have chosen Randy McCleese, MSIS, MBA, former CHIME board chair and chief information officer at Methodist Hospital in Henderson, Ky., as the recipient of the 2017 John E. Gall Jr. CIO of the Year award.

Thumbnail

Part 2, Q&A with next HIMSS CEO Hal Wolf: Health IT industry shouldn’t fear AI

Embracing artificial intelligence (AI) technology is “a necessity” for the health IT industry, according to Harold “Hal” Wolf III, the next president and CEO of the Healthcare Information and Management Systems Society (HIMSS).

Thumbnail

Q&A with next HIMSS CEO Hal Wolf: 'Absolute gap' between IT vendors, providers

It’s been quite a long time since anyone except Stephen Lieber was been president and CEO of The Healthcare Information and Management Systems Society (HIMSS), but he’ll soon be handing over the reins after 17 years to Harold “Hal” Wolf III, an alum of Kaiser Permanente and the Chartis Group as well as a HIMSS board member.

Thumbnail

Hal Wolf named new president, CEO of HIMSS

The Healthcare Information and Management Systems Society (HIMSS) has selected Harold “Hal” Wolf III, an alum of the Chartis Group and Kaiser Permanente, as its new president and CEO.

Thumbnail

Cleveland Clinic names Edward Marx as new CIO

Edward Marx will take over as the new chief information officer at Cleveland Clinic, effective Sept. 1.

Thumbnail

Cerner CEO Neal Patterson dies from cancer complications

Neal Patterson, the co-founder and CEO of health IT giant Cerner, died July 9 at age 67, according to a company statement.

Displaying 97 - 104 of 1011

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.